Back
Amedisys 10K Form
Buy
66
AMED
Amedisys
Last Price:
$93.63
Seasonality Move:
11.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | AMED/Amedisys Quarterly |
| 2023-10-25 | 10Q | AMED/Amedisys Quarterly |
| 2023-07-27 | 10Q | AMED/Amedisys Quarterly |
| 2023-05-04 | 10Q | AMED/Amedisys Quarterly |
| 2022-10-27 | 10Q | AMED/Amedisys Quarterly |
| 2022-07-28 | 10Q | AMED/Amedisys Quarterly |
Receive AMED News And Ratings
See the #1 stock for the next 7 days that we like better than AMED
AMED Financial Statistics
Sales & Book Value
| Annual Sales: | $2.3B |
|---|---|
| Cash Flow: | $-5.1M |
| Price / Cash Flow: | 14.19 |
| Annual Sales: | $36.55 |
| Price / Book: | 2.56 |
Profitability
| EPS (TTM): | 2.71000 |
|---|---|
| Net Income (TTM): | $89.8M |
| Gross Margin: | $1B |
| Return on Equity: | 7.55% |
| Return on Assets: | 4.21% |
Amedisys Earnings Forecast
Key Amedisys Financial Ratios
-
The Gross Profit Margin over the past 32 years for AMED is 43.34%.
-
The Selling, General & Administrative Expenses for AMED have been equal to 33.65% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 71.16% of Operating Income.
-
The Net Earning history of AMED is 1.84% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 18 years.
Amedisys Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | AMED |
| CUSIP: | 023436 |
| Website: | amedisys.com |
Debt
| Debt-to-Equity Ratio: | 0.31 |
|---|---|
| Current Ratio: | 1.29 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 71.44 |
|---|---|
| Forward P/E Ratio: | 18.09 |